Clinical trial
Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock: A Randomized Controlled Trial
NCT04819568 is registered in ClinicalTrials.gov with Institute of Liver and Biliary Sciences, India as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock: A Randomized Controlled Trial
- Lead sponsor
- Institute of Liver and Biliary Sciences, India
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 25, 2021
- Completion date
- March 19, 2022
- Enrollment
- 310 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.